Dr. Zeke Emmanuel, A University Of Pennsylvania

The article was written by Paul W. Abramowitz, Pharmacist. This is the first report that I have used that has been written in the pharmacist’s perspective. This person’s source of authority is written with the factual evidence that this pharmacist has gathered to his reasoning. The pharmacist is well prepared to write about this information because he is a professional in the pharmaceutical field. The pharmacist provides inflation percentages from year to year to show the constant increase in prescription drugs. This academic journal was found online as a link that I found within another document. The intended readers are general purchasers of medication, pharmacists, and physicians seeking affordable alternative medication for those with financial conflicts. The position being argued is drug prices are continuing to rise. The claim that is being made is the rise of medications is going to affect many people throughout the states. The author’s stance compares similarly to most other documents on rising drug pricing. In the United States rising drug prices are a common arguing point in the health career field. The author used 9 other sources of evidence to substantiate this document. The writer has used current, relevant, complete, and accurate evidence by using many other sources to form

The rise in drug prices is causing the public to ask why this is so and why there isn’t anything being done, or what the reason could be for sky high prices. Some of the reasons include pharmaceutical companies setting their drug prices

The prices of prescription drugs in the United States are by far the highest in the world. [1] On average, Europeans pay 40% less than Americans for the same medications. [2] Consumers have been resorting to several ways, sometimes putting themselves in harm’s way, to alleviate the burden of high prescription drug costs. Some buy their medications online or cross the borders to neighboring countries so they would be able to afford buying their needed medications. Others have resorted to the illegal act of selling their unused medications in online forums just to recover part of their expenses. Many factors contribute to the increased drug prices in the United States including research and

Over the last several years, beginning approximately around 2002 and reaching an all-time impossible high in 2016, prescribed drugs such as EpiPen, a life-saving allergy medication, or Bavencio, a cancer drug approved in March, or even older drugs such as insulin that has been around since 2002, have tripled in prices. Many drugs used for cancer, muscle dystrophy, bladder treatment, and more have prices ranging from $150,000 - $300,000 - a year. The director of health services research for the AARP Public Policy Institute, Leigh Purvis, says: “the simple answer is because there’s nothing stopping them”, referring to these pharmaceutical companies. Unlike many countries, The United States does not regulate drug prices, resulting in drug companies being able to charge whatever price they please. AARP Bulletin stated: “The supply of a newer medicine, however, is controlled entirely by the drug manufacturer that holds the patent rights. That gives the manufacturer a monopoly on the drug for the 20-year life of the patent. During that time, it is free to raise the price as frequently and as much as the market will bear.” AARP - The Ways of Drug Pricing.

Anyone who has purchased prescription medications has probably wondered why they cost so much, and rightfully so. Medication prices in the United States have been on a steady increase for decades, however, prices have been drastically increasing as of recent. Pharmaceutical companies have tried to justify these price increases due to the demand, the high cost of research, and the high costs of development and approval. Notwithstanding, the extent to which the prices have increased is not justifiable. Americans should be against these high medication prices and take action because pharmaceutical companies are taking advantage of our health care system in order to capitalize from the sick. In order shed some light on this issue, we must examine the magnitude, scope, and consequences of these rises in price.

U. S. citizens pay the highest prescription drug prices in the world. This is an injustice that must be corrected. The "U.S. forbids the import of prescription drugs by anyone other than the original U.S. manufacturer, and even then only when the drugs meet all the approval requirements of the U.S. Food and Drug Administration (FDA)" (Barlett & Steele, 2004). Prescription drug prices are outrageously high in the United States because of the influence of advertising on consumer purchasing, the misleading statements by pharmaceutical companies about the cost of research and development of new drugs, the manipulation of patent laws, the antiquated laws regarding importation of

In 2014, prescription drug costs made up 9.8% of total annual health care expenditures; retail prescription drug spending accounted for $297.7 billion (Hemphill, 2017). The need for prescription medication will continue to increase as the population ages. Chronic disease is also on the rise, and the pharmaceutical industry is under pressure to innovate. Healthcare cost are out of control, and medication seems to be the only solution to try and contain the costs. Doctors no longer focus on teaching patients how to care for themselves naturally. There are many herbs and supplements that can take the place of a prescription, but doctors write prescriptions for their own personal gain.

The prices in which the medication are set are necessary for research and development. Roy P. Vagelos, discusses about the problems regarding restricting pharmaceutical companies in the written source Are Prescription Drug Prices High?. For instance, it can reduce the profits to support research investments, since it costs at least $231 millions dollars in order to bring one new prescription medicine to the market and in a pharmaceutical company like Merck, there are at least 4500 researchers who work to develop products (Vagelos 1). In other words, it costs millions for researches to develop at least one new drug to present to the market and it also costs to pay researchers to help develop these new drugs. In addition, the article The Real Cost of “High Priced” Drugs,

In contrast to the newer prescription drugs, already existing prescription drugs cumulatively increased 81% from 2005 to 2013. Of these prescription drugs, the ones that treat chronic conditions have had a price increase of $4,336 in 2006 to $11,870 in 2013. These high price points on drugs that have been on the market for several years are a significant factor in the accelerating prescription drug inflammation. An example of rise in existing prescription drugs is Jazz Pharmaceuticals' Xyrem, a drug which purpose is to treat narcolepsy, was in 2007 priced at $2.04 per 1-milliliter dose. In 2014, Jazz Pharmaceuticals' Xyrem was priced at $19.40 per 1-milliliter dose. This means that there was 841% price increase over the course of seven years on the same exact drug. Jazz Pharmaceuticals' is not the only company increasing its prescription drugs in such high amounts. Eli LIlly had a price increase of 350% over the course of 6 years from 2007 to 2013, and Mylan hiked its epipen cost that treats anaphylaxis by 220% in the same six years. Companies say these costs are higher due to a number of reasons. One being that the high costs of these prescription drugs are being used to help find more efficient cures to disease, saving money in the long run. Another being that everything in our economy is inflating so it is only natural that prescription drugs increase as well.

In the business of drug production over the years, there have been astronomical gains in the technology of pharmaceutical drugs. More and more drugs are being made for diseases and viruses each day, and there are many more drugs still undergoing research and testing. These "miracle" drugs are expensive, however, and many Americans cannot afford these prices.

For almost a year now, prescription drugs continue to be one the pressing issues in healthcare reform. Drug pricing specifically, has made its way center stage as a result of numerous revenue-lifting actions from pharmaceutical companies, the most recent case being the arrest of Turing Pharmaceuticals’ CEO, Martin Shkreli. Shkreli was arrested on federal fraud charges a week before Christmas, but his infamy stems from his company’s price jack of Daraprim, an anti-parasite drug that is pivotal in the treatment of cancer and HIV patients. In at least 14 states, legislators have introduced “drug pricing transparency” bills, which have been designed to gather information from pharmaceutical companies about the cost to manufacture drugs.

Are prescription drugs overprescribed? Are patients being prescribed the correct medications that they actually need? Are generic drugs doing the same for the human body that marked up brand name medications are? These are some of the public’s biggest questions that can be easily answered by research. Everyone is affected by medication and healthcare in general today. Many real life scenarios are offered throughout this writing to support the argument. The following thesis statement is a worldwide problem. Unfortunately, the United States has the largest problem with inflation of drug cost and over-prescription of medications. Many people are to blame: drug manufacturers, insurers, prescribers, educators, and many others. A change is needed.

Drug companies claim research and development costs justify the high cost of prescription medication. However, only three in 10 drugs launched are profitable, and there is more money spent on marketing the drug than

The high cost of Prescription Drugs is one of the significant issues in the USA for a long time and is rising much faster than the consumer inflation rate. The consumers pay two to three times more than the average cost of medications in the United States. A study by Kessekheim, Avron, and Sarpatwari (2016) shows that the major factors that affect the prices of the medications include are the manufacturer's exclusivity during the time of patents and rights to set the price of the medications. Apart from this corporate greed delayed the availability of generic drugs after the exclusivity period of the medications. Governments in most of the developed countries like Canada, UK, and Germany negotiates the price of the medications with the pharmaceuticals

In recent years there has been a huge hike in prices for prescription and over the counter drugs in the U.S. Some of the drugs are drugs that save lives. The price increase of drugs is not a new things and it is because of many economic reasons, how much it costs to make and develop and how much the patent owner wants to sell them. The main problem though lies with the American government not wanting to put regulations the drugs. Some of the drugs are drugs that don't really affect you as much such as Ibuprofen but some of the drugs are drugs that save people's lives and they need them. Those life saving drugs in particular are the ones with the most price increases. Unfortunately this problem is only a problem in America and in other countries such as